The aim of the GOULASH-PLUS study is to understand the influencing factors and to determine, which parameters should be measured to detect the early phase of CP.
Acute pancreatitis (AP) is an inflammatory condition, which can lead to late consequences. In 20 % of patients recurrent AP (RAP) develops and in 7-12 % chronic pancreatitis (CP) will occur. We do not have sufficient information to establish an evidence based statement to define early CP, or how to prevent its development. Moreover, we are also lacking information what to suggest our patients to prevent the development of CP.
